![FDA approves safety labeling changes regarding DPD deficiency for fluorouracil injection products – FDA Oncology](https://oncodaily.com/pub/uploads/2024/03/866eac2a-8597-41be-8894-4b96deeb48d1.jpeg)
Photo from fda.gov
Mar 26, 2024, 19:09
FDA approves safety labeling changes regarding DPD deficiency for fluorouracil injection products – FDA Oncology
FDA Oncology shared on X/Twitter:
“FDA approves safety labeling changes regarding DPD deficiency for fluorouracil injection products.”
Further details.
Source: FDA Oncology/X